0001646331-18-000002.txt : 20180305 0001646331-18-000002.hdr.sgml : 20180305 20180305135112 ACCESSION NUMBER: 0001646331-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180305 DATE AS OF CHANGE: 20180305 EFFECTIVENESS DATE: 20180305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Constance Therapeutics, Inc. CENTRAL INDEX KEY: 0001646331 IRS NUMBER: 475135880 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-306932 FILM NUMBER: 18665354 BUSINESS ADDRESS: STREET 1: 981 HOWARD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 510-455-1473 MAIL ADDRESS: STREET 1: 981 HOWARD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 D 1 primary_doc.xml X0708 D LIVE 0001646331 Constance Therapeutics, Inc. 681 HOWARD STREET SAN FRANCISCO CA CALIFORNIA 94103 510-455-1473 DELAWARE None None Corporation true 2015 Constance Finley 681 Howard Street San Francisco CA CALIFORNIA 94103 Executive Officer Director Promoter Other Decline to Disclose 06b false 2018-02-23 false true false 25000 4247514 4247480 34 false 9 0 0 0 false Constance Therapeutics, Inc. s/ Constance Finley Constance Finley Chief Executive Officer 2018-03-05